2022-12-15
For the first time, global comprehensive estimates of the burden of bacterial infections have been published. In 2019, 7.7 million deaths around the world were found to be linked to infections caused by 33 types of bacteria. That equals 1 in 8 of all global deaths. It also makes bacterial infections the second largest cause of death globally, after ischemic heart disease only. Bacterial infections have long been an underestimated cause of global health burden, calling for urgent strengthening of mitigation strategies. The study puts in spotlight the crucial importance of access to treatment with effective antibiotics for all health systems.
A new study has looked at 33 types of bacteria across 11 infectious syndromes to estimate burden of bacterial infections. The study was carried out by the Global Burden of Disease 2019 Antimicrobial Resistance collaborators, led by Institute for Health Metrics and Evaluation (IHME) and University of Oxford, and published in the Lancet. Among the data sources were more than 343 million individual records or bacterial isolates. The study presents, for the first time, global comprehensive estimates of the burden of bacterial infections – highlighting the impact of these infections .
Key facts from the study
- 7.7 million deaths around the world were found linked to bacterial infection (not including tuberculosis). That is 13.6%, or 1 in 8, of all global deaths.
- This makes bacterial infections the second-leading cause of death globally.
- More than half of these deaths are caused by only five types of bacteria:
– Staphylococcus aureus
– Escherichia coli
– Streptococcus pneumoniae
– Klebsiella pneumoniae
– Pseudomonas aeruginosa - Three types of infections were responsible for more than 75% of the deaths:
– Lower respiratory infections (such as pneumonia)
– Bloodstream infections
– Peritoneal and intra-abdominal infections - There are large differences in burden as well as distribution of bacterial pathogens across regions. Mortality rate was highest in sub-Saharan Africa, with 230 deaths per 100,000 population, and lowest in high-income countries at 52 deaths per 100,000 population.
Important conclusions from the study
For all 33 bacteria, effective antibiotics exist as treatment, yet we see disproportionally high mortality rates in low-and middle-income countries. As effective antimicrobials exist for all 33 of the investigated bacteria, the authors suggest that this might be attributable to inadequate access to effective antimicrobials, weak health systems and insufficient prevention programs.
The authors further highlight that although bacterial pathogens cause a substantial health burden, they are not a major focus of any global public health initiatives. They conclude that bacterial infections should be an urgent priority for intervention within the global health community, through for example:
- Building stronger health systems with more robust diagnostic infrastructure
- Implementing appropriate infection control and antimicrobial stewardship measures
- Infection prevention is the foundation to reducing the burden of infections – essential prevention strategies are key and should include:
– improved access to safe drinking water and sanitation facilities
– Increased rates of vaccination, new vaccine development - Improved access to the appropriate antibiotics
- A strategic approach and investments in developing new antibiotics are essential – to mitigate antibiotic resistance and bacterial infections in general.
Read more from ReAct
Antibiotic resistance claims more than 1,2 million lives a year, says new large study
Resetting the agenda for antibiotic resistance through a health systems perspective
More from "2022"
- 15 things that need to happen in 2023 – for a robust response on antibiotic resistance!
- 7.7 million people die from bacterial infections every year
- ReAct highlights during World Antimicrobial Awareness Week 2022
- Awareness walk in Lusaka, Zambia
- ReAct Asia Pacific: Competitions, webinars, social media campaigns and new Indonesian declaration on AMR
- Otto Cars awarded Research!Sweden’s Honorary Award
- Innovate4Health: 16 finalists from 12 countries!
- Otto Cars has dedicated his life to the fight against antibiotic resistance
- ReAct activities for World Antimicrobial Awareness Week 2022
- ReAct Asia Pacific: Antibiotic Smart Communities as a way forward
- Webinar ReAct Asia Pacific! Moving towards an Antibiotic Smart Community – the use of a novel indicator framework
- Join ReAct Latin America Meeting: Empowered Communities!
- The impact of antibiotic resistance on cancer treatment, especially in low-and middle-income countries, and the way forward
- Sweden: Pernilla’s 8-day old daughter died from sepsis – caused by resistant bacteria Klebsiella
- Five challenges that governments need to address in resolving the stagnation in antibiotic development
- The monkeypox outbreak: Need for antibiotic stewardship?
- Key takeaways from the ReAct Africa and South Centre Conference
- New ReAct Europe and EPHA position paper on EU incentives for new antibiotics development
- Launch of a new approach to antimicrobial stewardship in Zambia
- Time to register for the annual ReAct Africa and South Centre conference!
- Innovate4Health 2022: Call for student team applications!
- “Need to address the paradox of hospitals spreading disease” says new WHO report
- 5 takeaways from AMR Stockholm+50 event
- Student Tehseen Contractor
- ReAct Latin America: call to governments on the use of antimicrobials in intensive animal husbandry
- Join ReAct Stockholm+50 associated event! Global AMR response – What needs to be done?
- New opportunities for global action on AMR?
- Public hearings on elements to be included in a new international instrument on pandemic preparedness & response
- Policy briefing on WHO GAP AMR: 8 pillars of action to address global solutions to AMR
- India: State Action Plans on AMR in focus at stakeholder colloquium
- The silence is killing us – time to listen to the facts
- Access to clean water – a fairly inexpensive way to avoid infections
- Anna Sjöblom new Director ReAct Europe
- Dr. Hari Paraton: Drug resistance bacteria threatens lives of mothers and newborns
- Antibiotic resistance claims more than 1,2 million lives a year, says new large study
- Artificial intelligence – the future of antibiotic resistance prevention?